公司资料
Heron Therapeutics 股价、新闻与催化剂
- 股票代码:
- HRTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.32 USD (-4.96%)
收盘价
最后更新: 2026年8月17日
85.2M USD
市值
股价为何变动
As of Aug 17, 2026, HRTX closed down 4.96% at $0.3200. No new same-company headline was identified in the current news window.
公司概览
Acute-Care Medicines
Heron Therapeutics commercializes medicines used in surgical pain management and oncology supportive care. Its portfolio is designed for administration in hospitals, ambulatory surgery centers and infusion settings.
ZYNRELEF
ZYNRELEF is an extended-release local anesthetic combining bupivacaine and meloxicam for postoperative pain. Heron is developing a ready-to-use prefilled syringe intended to improve preparation and operating-room efficiency.
Oncology Supportive Care
CINVANTI and APONVIE are injectable antiemetic products used to prevent nausea and vomiting associated with chemotherapy or surgery. These products complement the company's acute-care commercial infrastructure.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。